Skip to content

Clinical trials

Terminated Phase 1/2 trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Status: Terminated Country / region: Singapore Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20093
20101
20122
20153
20163
20171
20181
20192
20201
20224
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
National Cancer Centre, Singapore2
ASLAN Pharmaceuticals1
Adherex Technologies, Inc.1
Alentis Therapeutics AG1
Amgen1
BioNTech SE1
Bristol-Myers Squibb1
Cordis US Corp.1
Cullinan Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular6
Carcinoma, Non-Small-Cell Lung3
Neoplasms3
Liver Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Bacterial Infections1
Biliary Tract Neoplasms1
COVID-191
Carcinoma, Ovarian Epithelial1
Carcinoma, Renal Cell1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.